Literature DB >> 16996744

Experimental determination of calibration settings of a commercially available radionuclide calibrator for various clinical measurement geometries and radionuclides.

A Ceccatelli1, M Benassi, M D'Andrea, P De Felice, A Fazio, S Nocentini, L Strigari.   

Abstract

Following the approach of the National Primary Laboratory of the UK (NPL) for the calibration of radionuclide calibrators, but using a commercially available instrument with no data available in the literature, the radionuclide calibrator response was investigated as a function of different measurement geometries at the "Regina Elena" National Cancer Institute (IRE) in Rome. Working with Italian National Metrology Institute for ionising radiation quantities (ENEA-INMRI), specific calibration factors with traceability to national primary standards were determined for different types of glass vials, solid capsules and plastic syringes, investigating three radionuclides with different energy spectra (Tc-99m, In-111, I-131). For each kind of syringe, calibration correction factors for different filling volumes were calculated. For Tc-99m and I-131 the difference between measured and true activity was in the range 2-7%, depending on measurement geometry. For In-111 a large percentage deviation from the true activity value was found in each geometry considered, reaching 35%. The magnitude of this difference is particularly dependent on the energies of the emitted photons.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16996744     DOI: 10.1016/j.apradiso.2006.06.009

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  4 in total

1.  Deviation in the predefined calibration factors of the dose calibrators and the associated inaccuracy in the radioactivity measurements of beta-gamma emitters.

Authors:  Sarika Sharma; Baljinder Singh; Ashwani Koul; Bhagwant Rai Mittal
Journal:  Indian J Nucl Med       Date:  2015 Apr-Jun

2.  The role of dosimetry and biological effects in metastatic castration-resistant prostate cancer (mCRPC) patients treated with 223Ra: first in human study.

Authors:  Rosa Sciuto; Sandra Rea; Sara Ungania; Antonella Testa; Valentina Dini; Maria Antonella Tabocchini; Clarice Patrono; Antonella Soriani; Valentina Palma; Raffaella Marconi; Lidia Strigari
Journal:  J Exp Clin Cancer Res       Date:  2021-09-06

3.  Precise activity measurements of medical radionuclides using an ionization chamber: a case study with Terbium-161.

Authors:  Frédéric Juget; Zeynep Talip; Youcef Nedjadi; M Teresa Durán; Pascal V Grundler; Jan Rijn Zeevaart; Nicholas P van der Meulen; Claude Bailat
Journal:  EJNMMI Phys       Date:  2022-03-14

4.  Comparison of methods to determine accurate dose calibrator activity measurements.

Authors:  Lidia Strigari; Marcello Benassi; Pierino De Felice; Marco D'Andrea; Aldo Fazio; Sandro Nocentini; Annelisa d'Angelo; Alessia Ceccatelli
Journal:  J Exp Clin Cancer Res       Date:  2008-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.